WCN26-2486 THE DILEMMA OF INDUCTION IMMUNOSUPPRESSION IN LOW IMMUNOLOGICAL RISK KIDNEY TRANSPLANT RECIPIENTS- A PROSPECTIVE RANDOMISED STUDY FROM EASTERN INDIA COMPARING BASILIXIMAB VERSUS NO INDUCTION IMMUNOSUPPRESSION

Read full text Summarise with VIRAT
Authors: Varun Gosain, S. Rout
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Induction immunosuppression decreases the risk for acute rejection and improves graft outcomes in kidney transplant recipients but its role in low immunological risk group of patients is controversial. The objective of this study was to evaluate the impact of induction with basiliximab versus no induction therapy on outcomes in low immunological risk kidney transplant recipients (KTRs).

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Transplantation: Methods and Outcomes Organ Donation and Transplantation

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105454–105454
Publication date
25 March 2026
Language
EN